LivaNova PLC (NASDAQ:LIVN) saw unusually-strong trading volume on Wednesday . Approximately 1,208,313 shares were traded during mid-day trading, an increase of 171% from the previous session’s volume of 445,067 shares.The stock last traded at $61.23 and had previously closed at $54.44.

Separately, Piper Jaffray Cos. reaffirmed an “overweight” rating and issued a $59.00 price target (down previously from $61.00) on shares of LivaNova PLC in a research note on Thursday, July 7th. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $66.25.

The company’s market cap is $2.99 billion. The company has a 50-day moving average of $50.62 and a 200-day moving average of $52.66.

In other LivaNova PLC news, Director Alfred J. Novak sold 4,000 shares of the company’s stock in a transaction dated Friday, May 6th. The shares were sold at an average price of $51.12, for a total value of $204,480.00. Following the transaction, the director now owns 13,020 shares of the company’s stock, valued at $665,582.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Daniel Jeffrey Moore sold 1,000 shares of the company’s stock in a transaction dated Tuesday, May 24th. The shares were sold at an average price of $50.07, for a total transaction of $50,070.00. Following the completion of the transaction, the director now directly owns 64,137 shares in the company, valued at approximately $3,211,339.59. The disclosure for this sale can be found here.

A number of hedge funds and institutional investors recently bought and sold shares of the stock. Wells Fargo & Company MN bought a new position in LivaNova PLC during the fourth quarter worth approximately $30,246,000. Swiss National Bank bought a new position in LivaNova PLC during the fourth quarter worth approximately $3,421,000. State Board of Administration of Florida Retirement System bought a new position in LivaNova PLC during the fourth quarter worth approximately $1,390,000. Comerica Bank bought a new position in LivaNova PLC during the fourth quarter worth approximately $1,542,000. Finally, New York State Common Retirement Fund bought a new position in LivaNova PLC during the fourth quarter worth approximately $2,404,000.

LivaNova PLC is a United Kingdom-based medical technology company. The Company focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company operates under three business units: Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. The Company provides solutions for patients, healthcare professionals and healthcare systems.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.